Follistatin 344
Blocks the brake on muscle growth for rapid lean mass.
Early / anecdotalOverview
At a glance
Combining
Stacks well with: IGF-1 LR3
Safety
Powerful; limited human safety data.
Regulatory: Research compound.
Not appropriate if: cancer-history.
Questions
What is myostatin and why does blocking it matter?⌄
Myostatin is a protein your own muscle cells produce that limits muscle growth. It acts as a ceiling on how much lean mass you can build. Follistatin 344 blocks it, removing that ceiling.
How does Follistatin 344 work?⌄
It binds to myostatin directly, preventing it from activating its receptor on muscle cells. With myostatin blocked, the natural brake on muscle growth is removed.
Who uses Follistatin 344?⌄
People with a primary goal of rapid lean mass accumulation. It is not a general wellness compound - it is specifically oriented toward serious muscle building.
How is it taken?⌄
Subcutaneous injection, in short pulsed cycles. Dose, frequency, and exact cycle structure are all set at consult.
Who should NOT use this compound?⌄
Anyone with a history of cancer is excluded. The growth-promoting mechanism requires careful clinical evaluation in that context.
How strong is the evidence?⌄
Evidence is classified as anecdotal. Human safety data is limited. This is a research compound, not FDA-approved, and it is described in the record as 'powerful' with limited human safety characterization.
Can it be stacked with anything?⌄
It stacks with IGF-1 LR3 for compounded anabolic effect. No avoidance conflicts are listed.
Want a personalized protocol?
Exact dosing is set with a licensed provider in the PepDepo network. This page is education, not a prescription.
Book a consultEducation only, not medical advice. Peptides discussed are for informational purposes and many are not FDA-approved. Eligibility, prescribing, compounding, and dispensing are handled by appropriately licensed entities. Exact protocols and dosing are set with a licensed provider in the PepDepo network at consult. Content is pending clinical review.